PMID- 23123667 OWN - NLM STAT- MEDLINE DCOM- 20130926 LR - 20211021 IS - 1718-4304 (Electronic) IS - 0896-8608 (Print) IS - 0896-8608 (Linking) VI - 33 IP - 2 DP - 2013 Mar-Apr TI - Ultrafiltration characteristics of glucose polymers with low polydispersity. PG - 124-31 LID - 10.3747/pdi.2012.00009 [doi] AB - BACKGROUND: Icodextrin, a glucose polymer with a polydispersity [ratio of weight-average molecular weight (Mw) to number-average molecular weight] of approximately 2.6, has been shown, compared with glucose, to provide superior ultrafiltration (UF) efficiency [ratio of UF to carbohydrate (CHO) absorbed] when used as an osmotic agent during a long-dwell peritoneal dialysis exchange. In an experimental rabbit model, we evaluated the effect of Mw on the UF and UF efficiency of glucose polymers with low polydispersity. METHODS: A crossover trial in female New Zealand White rabbits (2.20 - 2.65 kg) with surgically implanted peritoneal catheters evaluated two glucose polymers at nominal concentrations of 7.5 g/dL: a 6K polymer (Mw: 6.4 kDa; polydispersity: 2.3) and a 19K polymer (Mw: 18.8 kDa; polydispersity: 2.0). Rabbits were randomized to receive either the 6K (n = 11) or the 19K (n = 12) solution during the first exchange (40 mL/kg body weight). The alternative solution was evaluated in a second exchange 3 days later. During each 4-hour dwell, the UF and total glucose polymer CHO absorbed were determined. RESULTS: The UF was higher for the 6K (p < 0.0001) than for the 19K polymer (mean +/- standard deviation: 73.6 +/- 30.8 mL vs. 43.0 +/- 20.2 mL), as was the amount of CHO absorbed (42.5% +/- 9.8% vs. 35.7% +/- 11.0%, p = 0.021). In spite of higher CHO absorption, an approximately 50% higher (p = 0.029) UF efficiency was achieved with the 6K polymer (28.3 +/- 18.8 mL/g) than with the 19K polymer (19.0 +/- 11.3 mL/g). The results were independent of the order of the experimental exchanges. CONCLUSIONS: Glucose polymers with low polydispersity are effective osmotic agents in a rabbit model. The low-Mw polymer was more effective at generating UF and had a higher UF efficiency, but those results came at the expense of the polymer being more readily absorbed from the peritoneal cavity. FAU - Leypoldt, John K AU - Leypoldt JK AD - Medical Products (Renal), Baxter Healthcare Corporation, McGaw Park, Illinois, USA. ken_leypoldt@baxter.com FAU - Hoff, Catherine M AU - Hoff CM FAU - Piscopo, Dean AU - Piscopo D FAU - Carr, Seraya N AU - Carr SN FAU - Svatek, Jessica M AU - Svatek JM FAU - Holmes, Clifford J AU - Holmes CJ LA - eng PT - Journal Article DEP - 20121101 PL - United States TA - Perit Dial Int JT - Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis JID - 8904033 RN - 0 (Dialysis Solutions) RN - 0 (Glucans) RN - 2NX48Z0A9G (Icodextrin) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Absorption MH - Animals MH - Dialysis Solutions/*pharmacokinetics MH - Disease Models, Animal MH - Female MH - Glucans/*pharmacokinetics MH - Glucose/*pharmacokinetics MH - Icodextrin MH - Molecular Weight MH - Osmosis/drug effects MH - *Peritoneal Dialysis MH - Rabbits MH - Renal Insufficiency/*metabolism/therapy MH - Ultrafiltration PMC - PMC3598102 EDAT- 2012/11/06 06:00 MHDA- 2013/09/27 06:00 PMCR- 2014/03/01 CRDT- 2012/11/06 06:00 PHST- 2012/11/06 06:00 [entrez] PHST- 2012/11/06 06:00 [pubmed] PHST- 2013/09/27 06:00 [medline] PHST- 2014/03/01 00:00 [pmc-release] AID - pdi.2012.00009 [pii] AID - 10.3747/pdi.2012.00009 [doi] PST - ppublish SO - Perit Dial Int. 2013 Mar-Apr;33(2):124-31. doi: 10.3747/pdi.2012.00009. Epub 2012 Nov 1.